|
Volumn 34, Issue 10, 2003, Pages
|
In vivo platelet activation in ischemic stroke patients.
a a a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BIOLOGICAL MARKER;
FIBRINOGEN RECEPTOR;
LEUKOCYTE ANTIGEN;
LYSOSOMAL PROTEIN GP53;
PADGEM PROTEIN;
CEREBROVASCULAR ACCIDENT;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
FEMALE;
FLOW CYTOMETRY;
HUMAN;
IMMUNOPHENOTYPING;
LABORATORY DIAGNOSIS;
MALE;
METABOLISM;
MIDDLE AGED;
NOTE;
PATHOPHYSIOLOGY;
PHYSIOLOGY;
PREDICTION AND FORECASTING;
REPRODUCIBILITY;
SAMPLE SIZE;
THROMBOCYTE;
THROMBOCYTE ACTIVATION;
ANTIGENS, CD;
BIOLOGICAL MARKERS;
BLOOD PLATELETS;
CEREBROVASCULAR ACCIDENT;
FALSE NEGATIVE REACTIONS;
FEMALE;
FLOW CYTOMETRY;
HUMANS;
IMMUNOPHENOTYPING;
MALE;
MIDDLE AGED;
P-SELECTIN;
PLATELET ACTIVATION;
PLATELET MEMBRANE GLYCOPROTEINS;
PREDICTIVE VALUE OF TESTS;
REPRODUCIBILITY OF RESULTS;
SAMPLE SIZE;
MLCS;
MLOWN;
|
EID: 0242348782
PISSN: None
EISSN: 15244628
Source Type: Journal
DOI: 10.1161/01.str.0000092400.93742.81 Document Type: Note |
Times cited : (8)
|
References (0)
|